Goldman Sachs Upgrades Alexion Pharmaceuticals (ALXN) to Buy

October 28, 2016 7:49 AM EDT
Get Alerts ALXN Hot Sheet
Price: $135.30 --0%

Rating Summary:
    20 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 16 | New: 50
Trade ALXN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Goldman Sachs upgraded Alexion Pharmaceuticals (NASDAQ: ALXN) from Neutral to Buy with a price target of $158.00.

For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.

Shares of Alexion Pharmaceuticals closed at $131.37 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Upgrades

Related Entities

Goldman Sachs

Add Your Comment